Protective Effect of Maternal First-Trimester Low Body Mass Index Against Macrosomia: A 10-Year Cross-Sectional Study
Open Access
- 10 February 2022
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 805636
Abstract
Objective: We aimed to assess whether maternal first-trimester low body mass index (BMI) has a protective effect against macrosomia.Methods: This was a cross-sectional study from January 1, 2011, to June 30, 2021, and 84,900 participants were included. The predictive performance of maternal first-trimester and parental pre-pregnancy BMI for macrosomia was assessed using the area under the receiver-operating characteristics curve (AUC). Multivariate logistic regression analyses were performed to evaluate the independent effect of maternal first-trimester low BMI on macrosomia. Interactions were investigated to evaluate the potential variation of the effect of first-trimester low BMI across different groups. Furthermore, interactions were also examined across groups determined by multiple factors jointly: a) gestational diabetes mellitus (GDM)/GDM history status, parity, and maternal age; and b) GDM/GDM history status, fetal sex, and season of delivery.Results: The proportion of macrosomia was 6.14% (5,215 of 84,900). Maternal first-trimester BMI showed the best discrimination of macrosomia (all Delong tests: P < 0.001). The protective effect of maternal first-trimester low BMI against macrosomia remained significant after adjusting for all confounders of this study [adjusted odds ratios (aOR) = 0.37, 95% CI: 0.32–0.43]. Maternal first-trimester low BMI was inversely associated with macrosomia, irrespective of parity, fetal sex, season of delivery, maternal age, and GDM/GDM history status. The protective effect was most pronounced among pregnant women without GDM/GDM history aged 25 to 29 years old, irrespective of parity (multipara: aOR = 0.32, 95% CI: 0.22–0.47; nullipara: aOR = 0.32, 95% CI: 0.24–0.43). In multipara with GDM/GDM history, the protective effect of low BMI was only observed in the 30- to 34-year-old group (aOR = 0.12, 95% CI: 0.02–0.86). For pregnant women without GDM/GDM history, the protective effect of maternal first-trimester low BMI against macrosomia was the weakest in infants born in winter, irrespective of fetal sex (female: aOR = 0.45, 95% CI: 0.29–0.69; male: aOR = 0.39, 95% CI: 0.28–0.55).Conclusion: Maternal first-trimester low BMI was inversely associated with macrosomia, and the protective effect was most pronounced among 25- to 29-year-old pregnant women without GDM/GDM history and was only found among 30- to 34-year-old multipara with GDM/GDM history. The protective effect of maternal first-trimester low BMI against macrosomia was the weakest in winter among mothers without GDM/GDM history.Keywords
Funding Information
- National Key Research and Development Program of China (2016YFC1000101)
- China Postdoctoral Science Foundation
This publication has 36 references indexed in Scilit:
- Cesarean Scar Pregnancies: A Systematic Review of Treatment OptionsJournal of Minimally Invasive Gynecology, 2017
- Association of Gestational Weight Gain With Maternal and Infant OutcomesJAMA, 2017
- Association between perinatal outcomes and maternal pre‐pregnancy body mass indexObesity Reviews, 2016
- Prevalence of Adverse Pregnancy Outcomes, by Maternal Diabetes Status at First and Second Deliveries, Massachusetts, 1998–2007Preventing Chronic Disease, 2015
- The prevalence of gestational diabetes mellitus recurrence—effect of ethnicity and parity: a metaanalysisAmerican Journal of Obstetrics and Gynecology, 2015
- ABCC8R1420H Loss-of-Function Variant in a Southwest American Indian Community: Association With Increased Birth Weight and Doubled Risk of Type 2 DiabetesDiabetes, 2015
- A gender-sensitised weight loss and healthy living programme for overweight and obese men delivered by Scottish Premier League football clubs (FFIT): a pragmatic randomised controlled trialThe Lancet, 2014
- Macrosomia in 23 developing countries: an analysis of a multicountry, facility-based, cross-sectional surveyThe Lancet, 2013
- The Relative Contribution of Prepregnancy Overweight and Obesity, Gestational Weight Gain, and IADPSG-Defined Gestational Diabetes Mellitus to Fetal OvergrowthDiabetes Care, 2012
- Maternal Glycemia and Risk of Large-for-Gestational-Age Babies in a Population-Based ScreeningDiabetes Care, 2009